Submit Deal

KYOWA KIRIN CO. LTD

HQ - Tokyo

Summary

Kyowa Kirin is a global specialty pharmaceutical company that applies biotechnologies to discover and deliver novel medicines.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 580 M

Avg. Deal Size£ 193 M

Market Context

Senior Management

Masashi Miyamoto
CEO
Andrew Aristidou
CFO
Abdul Mullick
Chief International Business Officer

Senior Management

Masashi Miyamoto
CEO
Andrew Aristidou
CFO
Abdul Mullick
Chief International Business Officer

Sort

04 Oct 2022|United States|Pharmaceuticals

Target: CELLARITY

Bidder: FLAGSHIP PIONEERING

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

2 Target | 4 Bidder

£ 107 M

Value

24 Nov 2022|United Kingdom|Pharmaceuticals

Target: KYOWA KIRIN / GRUNENTHAL JOINT VENTURE

Bidder: GRUNENTHAL

4 Service Providers

4 Bidder

33 Dealmakers

33 Bidder

n/a

Value

05 Oct 2023|United Kingdom|Biotechnology

Target: ORCHARD THERAPEUTICS

Bidder: KYOWA KIRIN CO. LTD

8 Service Providers

5 Target | 3 Bidder

21 Dealmakers

15 Target | 6 Bidder

£ 394 M

Value

01 Aug 2024|China|Pharmaceuticals

Target: KYOWA KIRIN (CHINA BUSINESS)

Bidder: HONG KONG WINHEALTH PHARMA GROUP

2 Service Providers

1 Bidder | 1 Vendor

5 Dealmakers

1 Bidder | 4 Vendor

£ 77 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy